ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 126 filers reported holding ATEA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23 | -17.9% | 7,570 | 0.0% | 0.00% | – |
| Q2 2023 | $28 | +3.7% | 7,570 | -4.5% | 0.00% | – |
| Q1 2023 | $27 | -42.6% | 7,927 | -18.2% | 0.00% | – |
| Q4 2022 | $47 | -99.9% | 9,696 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $55,000 | -20.3% | 9,696 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $69,000 | +19.0% | 9,696 | +20.0% | 0.00% | – |
| Q1 2022 | $58,000 | -81.2% | 8,080 | -7.9% | 0.00% | -100.0% |
| Q3 2021 | $308,000 | +53.2% | 8,773 | -6.2% | 0.00% | +50.0% |
| Q2 2021 | $201,000 | – | 9,353 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $22,222,000 | 1.76% |
| EcoR1 Capital, LLC | 5,376,134 | $48,063,000 | 1.53% |
| Cormorant Asset Management, LP | 1,679,442 | $15,014,000 | 0.89% |
| CM Management, LLC | 100,000 | $894,000 | 0.68% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 596,800 | $5,335,000 | 0.40% |
| PDT Partners, LLC | 278,487 | $2,490,000 | 0.19% |
| Ikarian Capital, LLC | 116,600 | $1,043,000 | 0.16% |
| HighVista Strategies LLC | 20,659 | $185,000 | 0.15% |
| Aristides Capital LLC | 35,132 | $314,000 | 0.14% |
| Parkwood LLC | 71,932 | $643,000 | 0.11% |